Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Anticancer Research|May 17, 2019
Platelet Depletion/Transfusion as a Lethal Factor in a Colitis-associated Cancer Mouse ModelAnastasios Angelou, Efstathios Antoniou, Anastasia Pikouli, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 13, 2017
Increased kinetic growth rate during late phase liver regeneration impacts the risk of tumor recurrence after colorectal liver metastases resectionGeorgios A Margonis, Kazunari Sasaki, Nikolaos Andreatos, et al.
Current Medicinal Chemistry|September 16, 2021
Histone Deacetylases and their Inhibitors in Colorectal Cancer Therapy: Current Evidence and Future ConsiderationsNikolaos Garmpis, Christos Damaskos, Anna Garmpi, et al.
Annals of Surgical Oncology|December 28, 2023
Is Precision Surgery Applicable to Colorectal Liver Metastases? A Systematic Review and Meta-analysis of Studies that Investigate the Association of Surgical Technique with Outcomes in the Context of Distinct Tumor BiologyEmmanouil Pikoulis, Dimitrios Papaconstantinou, Anastasia Pikouli, et al.
BMC Cancer|August 4, 2009
Evaluation of DNA ploidy in relation with established prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysisNikolas Tsavaris, Nicolaos Kavantzas, Kostantinos Tsigritis, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|April 11, 2018
The Prognostic Value of Varying Definitions of Positive Resection Margin in Patients with Colorectal Cancer Liver MetastasesJane Wang, Georgios Antonios Margonis, Neda Amini, et al.
Anticancer Research|September 29, 2020
The Interplay Between Innate Immunity (TLR-4) and sCD40L in the Context of an Animal Model of Colitis-associated CancerAnastasios Angelou, Apostolos E Papalois, Efstathios Antoniou, et al.
Journal of Surgical Oncology|December 28, 2020
The interplay of KRAS mutational status with tumor laterality in non-metastatic colorectal cancer: An international, multi-institutional study in patients with known KRAS, BRAF, and MSI statusCarsten Kamphues, Shigenori Kadowaki, Neda Amini, et al.
Annals of Surgical Oncology|October 8, 2024
Evaluating Combinations of Biological and Clinicopathologic Factors Linked to Poor Outcomes in Resected Colorectal Liver Metastasis: An External Validation StudyKazunari Sasaki, Jane Wang, Carsten Kamphues, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|April 14, 2019
KRAS mutational status impacts pathologic response to pre-hepatectomy chemotherapy: a study from the International Genetic Consortium for Liver MetastasesGeorgios A Margonis, Neda Amini, Nikolaos Andreatos, et al.
Pageof 4